Cafepharma Today

May 19 2025 - Regeneron wins bid to buy 23andMe out of bankruptcy
Regeneron wins bid to buy 23andMe out of bankruptcy
Amid US investment push, Lilly eyes Houston as potential home for $5.9B API plant
Japan follows UK in GSK's comeback tour for Blenrep
FDA clears Novavax’s COVID-19 vaccine with usage restrictions
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Celladon's Mydicar candidate granted breakthrough therapy designation by FDA
The Fly on the Wall
Thursday, April 10, 2014 - 10:39am
tags:
Celladon, Mydicar, breakthrough therapies, FDA, heart failure
3 Breast Cancer Drugs With Big Potential
Motley Fool
Thursday, April 10, 2014 - 10:37am
tags:
breast cancer, Pfizer, Novartis, Eli Lilly, LEE011, LY2835219, palbociclib, CDK 4/6 inhibitors
GlycoMimetics: A Promising Sickle Cell Disease Play
Seeking Alpha
Thursday, April 10, 2014 - 10:35am
tags:
GlycoMimetics, sickle cell disease, GMI-1070, GMI-1271
Chimerix CEO Out In Wake Of Josh Hardy Compassionate Use Media Frenzy
Forbes
Thursday, April 10, 2014 - 10:34am
tags:
Chimerix, compassionate use guidelines, CMX001
French plan to push copycat biotech drugs worries Big Pharma
Big Pharma
Thursday, April 10, 2014 - 8:19am
tags:
France, biosimilars
Data trove shows U.S. doctors reap millions from Medicare
Yahoo/Reuters
Thursday, April 10, 2014 - 7:50am
tags:
physicians, Medicare
Biogen's blood disorder drug succeeds in late-stage trial
Yahoo/Reuters
Thursday, April 10, 2014 - 7:49am
tags:
Biogen Idec, Biovitrum, Eloctate, hemophilia A
[video] Eli Lilly CEO: We keep investing in R&D
CNBC
Thursday, April 10, 2014 - 7:46am
tags:
R&D, Eli Lilly, Pharma CEOs, John Lechleiter
IPO Preview: Adamas Pharmaceuticals
Seeking Alpha
Thursday, April 10, 2014 - 7:45am
tags:
IPOs, Adamas Pharmaceuticals
IPO Preview: Cerulean Pharma
Seeking Alpha
Thursday, April 10, 2014 - 7:44am
tags:
IPOs, Cerulean Pharma
Merck Data Show Potent Rival to Gilead’s Hepatitis C Pill
Bloomberg
Thursday, April 10, 2014 - 7:39am
tags:
Merck, Gilead, hepatitis C, MK-5172, MK-8742, Sovaldi
Bristol-Myers hepatitis C treatment cures up to 90 pct -study
Yahoo/Zacks.com
Thursday, April 10, 2014 - 7:35am
tags:
Bristol-Myers Squibb, hepatitis C, daclatasvir, asunaprevir
Novartis names two new leaders to growth drivers Alcon, Sandoz
Fierce Pharma
Wednesday, April 9, 2014 - 9:43pm
tags:
Alcon, Sandoz, Novartis
Researchers, regulators and Roche row over stockpiled drug Tamiflu
Reuters
Wednesday, April 9, 2014 - 9:39pm
tags:
Roche, Tamiflu
Celgene Higher on Revlimid Patent Case Document Release
TheStreet.com
Wednesday, April 9, 2014 - 9:35pm
tags:
Celgene, Revlimid, patents
Ambit's Oncology Drug in Phase III
Yahoo/Zacks.com
Wednesday, April 9, 2014 - 9:34pm
tags:
Ambit Biosciences, quizartinib, acute myeloid leukemia
Why Does This Former Pharma King Keep Buying Shares Of Tribute Pharmaceuticals?
Seeking Alpha
Wednesday, April 9, 2014 - 9:29pm
tags:
Tribute Pharmaceuticals, John Gregory, Bezalip SR
Why The Federal Employees Health Benefits Letter Is A Big Deal For Belviq
Seeking Alpha
Wednesday, April 9, 2014 - 3:57pm
tags:
Belviq, obesity, HMOs, Arena Pharmaceuticals
Novartis, NEA join $188M gamble on China biotech fund
Fierce Biotech
Wednesday, April 9, 2014 - 11:51am
tags:
China, NEA, Novartis
Nektar reports positive preclinical data for two oncology programs
The Fly on the Wall
Wednesday, April 9, 2014 - 11:50am
tags:
Nektar, NKTR-102, NKTR-214, breast cancer

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline
Obesity Without Metabolic Dysfunction?
In the Pipeline
New Cell Therapy For Resistant Hodgkins Patients
In the Pipeline
Escape From the Lysosome
In the Pipeline
Heavy Water in Your NMR Experiments, And Elsewhere
In the Pipeline
GIPR: Agonists and Antagonists Do the Same Thing, But How
In the Pipeline
Mutant Proteins Classified
In the Pipeline
The Continuing Crisis, Part XIV: The Trumpist Worldview
In the Pipeline
Whole Lotta Snakin' Going On
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.